[1]
C. L. D. Gutierrez, A. K. H. Quero-Taggaoa, T. C. F. Uy, and J. A. D. Veloso, “High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax”, J Med Cases, vol. 17, no. 4, pp. 146–152, Jan. 2026, doi: 10.14740/jmc5237.